Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
101M
-
Number of holders
-
187
-
Total 13F shares, excl. options
-
67.1M
-
Shares change
-
+3.21M
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
+$71.8M
-
Put/Call ratio
-
1.13
-
Number of buys
-
104
-
Number of sells
-
-64
-
Price
-
$24.05
Significant Holders of Beam Therapeutics Inc. - Common Stock (BEAM) as of Q3 2023
230 filings reported holding BEAM - Beam Therapeutics Inc. - Common Stock as of Q3 2023.
Beam Therapeutics Inc. - Common Stock (BEAM) has 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.1M shares
of 101M outstanding shares and own 66.73% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (8.78M shares), VANGUARD GROUP INC (6.81M shares), BlackRock Inc. (6.52M shares), FMR LLC (6.5M shares), FARALLON CAPITAL MANAGEMENT LLC (4.48M shares), Temasek Holdings (Private) Ltd (4.32M shares), STATE STREET CORP (4.14M shares), MWG Management Ltd. (2.35M shares), Nikko Asset Management Americas, Inc. (1.64M shares), and Sumitomo Mitsui Trust Holdings, Inc. (1.64M shares).
This table shows the top 187 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.